Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
about
An update on renal involvement in hemophagocytic syndrome (macrophage activation syndrome)Hemophagocytic lymphohistiocytosis: review of etiologies and managementGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patientsHow I treat hemophagocytic lymphohistiocytosis.Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis.The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailablePEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.A Case of Macrophage Activation Syndrome with Acute Respiratory Distress Syndrome.Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy.Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature.Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management.Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.Advances in understanding the pathogenesis of HLH.TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review.Predictors of the response to treatment in acute lupus hemophagocytic syndrome.Clinical features and correct diagnosis of macrophage activation syndrome.Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?Hemophagocytic syndrome after liver transplantation: report of two cases.What intensivists need to know about hemophagocytic syndrome: an underrecognized cause of death in adult intensive care units.Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab.Hemophagocytic lymphohistiocytosis after allogeneic bone marrow transplantation during chronic norovirus infection.Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.Hemophagocytic Syndrome Complicated with Dermatomyositis Controlled Successfully with Infliximab and Conventional Therapies.Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis.Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy.Efficacy of Cyclosporine in the Induction and Maintenance of Remission in a Systemic Lupus Erythematosus Patient Presenting with Macrophage-Activating Syndrome.Disseminated infection to immune activation.Macrophage Activation Syndrome, Glomerulonephritis, Pericarditis, and Retinal Vasculitis as Initial Presentation of Systemic Lupus Erythematosus
P2860
Q26751532-B3EA1F65-66DE-4DBD-BE8E-E1242263AAA5Q26830538-4238C9CD-FEE8-4332-B9CE-4B32AD13E4EFQ30276550-0F04784A-8892-4C22-85C0-45AF45158338Q33420069-956AC7F2-E8B0-49A5-8809-5E5C809649FAQ35483540-47D12897-DF4E-4AFB-B8D3-897F25A2A1B4Q36253959-0E6F105A-DF3D-4092-8A19-D6BC3D0243DBQ36686045-B03B18E3-EC7D-4BEE-835A-F9FF26AC432CQ37243949-3D44C25C-7E53-43D0-AF64-1D33A17A6DE0Q37353080-FA0069B0-F7CA-4D27-893E-E5FB458AB572Q37729056-40160C6C-2690-4701-98BF-BAA26986C374Q37784476-15128A46-36BD-4FEE-8100-C2EAA7203C84Q37837960-691B513A-F98B-405F-A5C2-D06485612805Q37993678-F63C3373-1317-4A3E-9BE4-0B0E33BE03BEQ38098232-E0507D5B-8FCC-4245-ADF1-496785E48CC2Q38164126-C94FFA25-6E54-40CA-94AF-4BEF4F6D5F84Q38267689-7B937967-8AF3-4EA4-905F-EAFD94702E5CQ38530013-62AAC125-DA3F-477A-A7D6-29EE17C5585AQ38637780-6372B9E0-CBFB-4D3F-8D75-113667FBF5CEQ40310367-8F651D2F-061D-4339-B317-4D46CF8D7CBAQ40336460-D2969B79-8E2A-452F-80F8-E7F63B04A7F6Q41923461-614B4201-B86D-4045-BE3F-7A96259FB475Q42260141-6EFFFFB8-2AFA-4566-A93D-C1F6408AA36FQ42278535-3842E48D-CEB6-45DB-A12B-6AD5C7DE13F3Q42576897-A367AEEF-9D7E-43B9-883E-4A0AA9E1B88BQ47124714-F980DBDA-4618-49F4-B0C1-C8B263EA9AFFQ47550133-CE0B8971-8952-4F29-8423-B342DA2D3CE5Q51310331-8B7D5F48-F338-4EA2-B943-854F4C2C794EQ54253814-7CBFD62B-CAA9-4792-B4B7-12F7FF20D945Q55222797-7D85D394-83DA-43F4-88B7-A1FBE3CFE34FQ57821249-33E5C527-3A47-44FD-A770-AFA650A57DAD
P2860
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
@en
type
label
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
@en
prefLabel
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
@en
P2093
P356
P1476
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
@en
P2093
Hiroshi Tsukamoto
Hisashi Gondo
Koji Nagafuji
Mine Harada
Shinsaku Imashuku
Tomoko Henzan
Toshihiro Miyamoto
P356
10.1002/AJH.20462
P577
2006-01-01T00:00:00Z